755 related articles for article (PubMed ID: 32407987)
1. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
3. Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
Cheng X; Hu J; Wang Y; Ye H; Li X; Gao Q; Li Z
J Diabetes Res; 2018; 2018():3071959. PubMed ID: 30402501
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
5. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway.
Shao Z; Shen Q; Kong M; Ni H; Hou X
Acta Biochim Pol; 2021 Feb; 68(1):119-126. PubMed ID: 33629579
[TBL] [Abstract][Full Text] [Related]
6. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
7. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
Wu ZL; Davis JRJ; Zhu Y
Biomed Res Int; 2020; 2020():8979270. PubMed ID: 33299886
[TBL] [Abstract][Full Text] [Related]
11. The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.
Liu S; Ai Q; Feng K; Li Y; Liu X
Apoptosis; 2016 Dec; 21(12):1366-1385. PubMed ID: 27738772
[TBL] [Abstract][Full Text] [Related]
12. Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3β signaling pathway.
Liu G; Zhang BF; Hu Q; Liu XP; Chen J
Biochem Biophys Res Commun; 2020 Oct; 531(2):242-249. PubMed ID: 32798018
[TBL] [Abstract][Full Text] [Related]
13. Troxerutin attenuates oxygen‑glucose deprivation and reoxygenation‑induced oxidative stress and inflammation by enhancing the PI3K/AKT/HIF‑1α signaling pathway in H9C2 cardiomyocytes.
Yu ZP; Yu HQ; Li J; Li C; Hua X; Sheng XS
Mol Med Rep; 2020 Aug; 22(2):1351-1361. PubMed ID: 32626962
[TBL] [Abstract][Full Text] [Related]
14. Methyl palmitate protects heart against ischemia/reperfusion-induced injury through G-protein coupled receptor 40-mediated activation of the PI3K/AKT pathway.
Shen YJ; Shen YC; Lee WS; Yang KT
Eur J Pharmacol; 2021 Aug; 905():174183. PubMed ID: 34015318
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
Liang S; Wang Y; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
[TBL] [Abstract][Full Text] [Related]
16. Sodium tanshinone IIA sulfonate protects rat myocardium against ischemia-reperfusion injury via activation of PI3K/Akt/FOXO3A/Bim pathway.
Zhang MQ; Zheng YL; Chen H; Tu JF; Shen Y; Guo JP; Yang XH; Yuan SR; Chen LZ; Chai JJ; Lu JH; Zhai CL
Acta Pharmacol Sin; 2013 Nov; 34(11):1386-96. PubMed ID: 24077633
[TBL] [Abstract][Full Text] [Related]
17. Impacts of delta 9-tetrahydrocannabinol against myocardial ischemia/reperfusion injury in diabetic rats: Role of PTEN/PI3K/Akt signaling pathway.
Zhao X; Gao Z; Wen W; Zheng S
Chin J Physiol; 2023; 66(6):446-455. PubMed ID: 38149557
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway.
Zeng C; Jiang W; Zheng R; He C; Li J; Xing J
PLoS One; 2018; 13(3):e0193845. PubMed ID: 29538428
[TBL] [Abstract][Full Text] [Related]
19. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol protects myocardial apoptosis induced by ischemia-reperfusion in rats with acute myocardial infarction via blocking P13K/Akt/e-NOS pathway.
Zhang X; Huang LF; Hua L; Feng HK; Shen B
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1789-1796. PubMed ID: 30840305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
